Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood sugar
Pharma
Lilly's Mounjaro scores in Type 2 diabetes trial in kids 10-17
A phase 3 trial of Eli Lilly's Mounjaro in kids ages 10-17 with Type 2 diabetes has demonstrated the drug's effectiveness in controlling blood sugar.
Kevin Dunleavy
Sep 18, 2025 11:22am
AZ's Farxiga follows Zynquista to FDA rejection in Type 1 diabetes
Jul 15, 2019 11:15am
Jardiance holds CV benefit regardless of blood sugar control
Sep 13, 2017 12:27pm
